相似文献
1
Pharmacogenetics of TNF inhibitor response in rheumatoid arthritis utilizing the two-component disease activity score.
Pharmacogenomics. 2020 Nov;21(16):1151-1156. doi: 10.2217/pgs-2020-0043. Epub 2020 Oct 30.
2
Validation of GWAS-Identified Variants for Anti-TNF Drug Response in Rheumatoid Arthritis: A Meta-Analysis of Two Large Cohorts.
Front Immunol. 2021 Oct 27;12:672255. doi: 10.3389/fimmu.2021.672255. eCollection 2021.
3
Correlation of C-reactive protein haplotypes with serum C-reactive protein level and response to anti-tumor necrosis factor therapy in UK rheumatoid arthritis patients: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohort.
Arthritis Res Ther. 2012 Oct 7;14(5):R214. doi: 10.1186/ar4052.
4
A longitudinal genome-wide association study of anti-tumor necrosis factor response among Japanese patients with rheumatoid arthritis.
Arthritis Res Ther. 2016 Jan 18;18:12. doi: 10.1186/s13075-016-0920-6.
5
Pre-treatment calprotectin (MRP8/14) provides no added value to testing CRP alone in terms of predicting response to TNF inhibitors in rheumatoid arthritis in a post hoc analysis.
Ann Rheum Dis. 2023 May;82(5):611-620. doi: 10.1136/ard-2022-222519. Epub 2023 Feb 21.
6
Lack of replication of genetic predictors for the rheumatoid arthritis response to anti-TNF treatments: a prospective case-only study.
Arthritis Res Ther. 2010;12(2):R72. doi: 10.1186/ar2990. Epub 2010 Apr 27.
7
Association of the multi-biomarker disease activity score with joint destruction in patients with rheumatoid arthritis receiving tumor necrosis factor-alpha inhibitor treatment in clinical practice.
Mod Rheumatol. 2016 Nov;26(6):850-856. doi: 10.3109/14397595.2016.1153449. Epub 2016 Mar 30.
8
Gene Polymorphisms as Potential Biomarkers of Disease Susceptibility and Response to TNF Inhibitors in Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Patients.
Front Immunol. 2021 Jun 11;12:631603. doi: 10.3389/fimmu.2021.631603. eCollection 2021.
9
Estimation of heritability of different outcomes for genetic studies of TNFi response in patients with rheumatoid arthritis.
Ann Rheum Dis. 2015 Dec;74(12):2183-7. doi: 10.1136/annrheumdis-2014-205541. Epub 2014 Aug 11.
10
Previously reported PDE3A-SLCO1C1 genetic variant does not correlate with anti-TNF response in a large UK rheumatoid arthritis cohort.
Pharmacogenomics. 2016 May;17(7):715-20. doi: 10.2217/pgs.16.16. Epub 2016 May 16.
引用本文的文献
1
Towards Personalized Medicine in Rheumatoid Arthritis.
Open Access Rheumatol. 2024 May 18;16:89-114. doi: 10.2147/OARRR.S372610. eCollection 2024.
2
Comprehensive genetic and functional analyses of Fc gamma receptors influence on response to rituximab therapy for autoimmunity.
EBioMedicine. 2022 Dec;86:104343. doi: 10.1016/j.ebiom.2022.104343. Epub 2022 Nov 11.
3
Pharmacogenetics of Drug Therapies in Rheumatoid Arthritis.
Methods Mol Biol. 2022;2547:527-567. doi: 10.1007/978-1-0716-2573-6_19.
本文引用的文献
1
Validity of a two-component imaging-derived disease activity score for improved assessment of synovitis in early rheumatoid arthritis.
Rheumatology (Oxford). 2019 Mar 1;58(8):1400-9. doi: 10.1093/rheumatology/kez049.
2
Genome-wide association study of response to tumour necrosis factor inhibitor therapy in rheumatoid arthritis.
Pharmacogenomics J. 2018 Sep;18(5):657-664. doi: 10.1038/s41397-018-0040-6. Epub 2018 Aug 31.
3
Systematic review and meta-analysis: pharmacogenetics of anti-TNF treatment response in rheumatoid arthritis.
Pharmacogenomics J. 2017 Oct;17(5):403-411. doi: 10.1038/tpj.2017.26. Epub 2017 Jun 13.
4
Impact of inadequate adherence on response to subcutaneously administered anti-tumour necrosis factor drugs: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohort.
Rheumatology (Oxford). 2015 Mar;54(3):494-9. doi: 10.1093/rheumatology/keu358. Epub 2014 Sep 10.
5
Estimation of heritability of different outcomes for genetic studies of TNFi response in patients with rheumatoid arthritis.
Ann Rheum Dis. 2015 Dec;74(12):2183-7. doi: 10.1136/annrheumdis-2014-205541. Epub 2014 Aug 11.
6
The role of depression, anxiety, fatigue, and fibromyalgia on the evaluation of the remission status in patients with rheumatoid arthritis.
J Rheumatol. 2014 Sep;41(9):1755-60. doi: 10.3899/jrheum.131171. Epub 2014 Aug 1.
7
Development and validation of modified disease activity scores in rheumatoid arthritis: superior correlation with magnetic resonance imaging-detected synovitis and radiographic progression.
Arthritis Rheumatol. 2014 Apr;66(4):794-802. doi: 10.1002/art.38304.
8
Genetics of rheumatoid arthritis contributes to biology and drug discovery.
Nature. 2014 Feb 20;506(7488):376-81. doi: 10.1038/nature12873. Epub 2013 Dec 25.
9
Impact of psychological factors on subjective disease activity assessments in patients with severe rheumatoid arthritis.
Arthritis Care Res (Hoboken). 2014 Jun;66(6):861-8. doi: 10.1002/acr.22249.
10
Genome-wide association study and gene expression analysis identifies CD84 as a predictor of response to etanercept therapy in rheumatoid arthritis.
PLoS Genet. 2013 Mar;9(3):e1003394. doi: 10.1371/journal.pgen.1003394. Epub 2013 Mar 28.
Zotero 插件